Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

By Chuansheng Guo, Shujun Xie, Zhexu Chi, Jinhua Zhang, Yangyang Liu, Li Zhang, Mingzhu Zheng, Xue Zhang, Dajing Xia, Yuehai Ke and 2 more. Immunity, 2016

692 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/a25c7d55319f0c4b9d1441f43c7b06e4d4d0841a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. E. Canfora
2. Ellen E. Blaak
3. Albert K. Groen
4. K. Verbeke
5. K. Scott
6. Yuan He

Citations in the corpus

• Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. (2019, positive): “, 2013) and to block inflammasome (Guo et al., 2016).”
• Short chain fatty acids in human gut and metabolic health. (2020, positive): “…have also reported an attenuation of body weight gain with butyrate administration (De Vadder et al. , 2014; Den Besten et al. , 2015; Dutzan et al. , 2017; Guo et al. , 2016; Henagan et al. , 2015; Hong et al. , 2016; Kang et al. , 2017; Lim et al. , 2012; Lu et al. , 2016; Zhou et al. , 2017).”
• The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation (2019, background): “showed a different inhibitory mechanism of NLRP3 phosphorylation at the same site [146].”